These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 22407996)

  • 21. [Antimicrobial therapy of Clostridium difficile infection. Systematic review and meta-analysis of the scientific evidence].
    Brodszky V; Gulácsi L; Ludwig E; Prinz G; Banai J; Reményi P; Strbák B; Kertész A; Kopcsóné Németh I; Zsoldiné Urbán E; Baji P; Péntek M
    Orv Hetil; 2013 Jun; 154(23):890-9. PubMed ID: 23728312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can we identify patients at high risk of recurrent Clostridium difficile infection?
    Kelly CP
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():21-7. PubMed ID: 23121551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
    Bouza E; Muñoz P; Alonso R
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():57-64. PubMed ID: 15997485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clostridium difficile associated diarrhea in the elderly patient].
    Pareja Sierra T; Hornillos Calvo M
    Rev Clin Esp; 2007 Feb; 207(2):86-90. PubMed ID: 17397570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing downstream Clostridium difficile infections with upstream antibiotic management.
    Malkan AD; Scholand SJ
    Med Hypotheses; 2012 Jan; 78(1):136-7. PubMed ID: 22079651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium difficile infection.
    Kuipers EJ; Surawicz CM
    Lancet; 2008 May; 371(9623):1486-8. PubMed ID: 18456087
    [No Abstract]   [Full Text] [Related]  

  • 29. Clostridium difficile infection: a comprehensive review.
    Kachrimanidou M; Malisiovas N
    Crit Rev Microbiol; 2011 Aug; 37(3):178-87. PubMed ID: 21609252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
    Lupse M; Flonta M; Cioara A; Filipescu I; Todor N
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):397-403. PubMed ID: 24369321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options.
    Lo Vecchio A; Zacur GM
    Curr Opin Gastroenterol; 2012 Jan; 28(1):1-9. PubMed ID: 22134217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of infections associated with Clostridium difficile].
    Szczesny A; Martirosian G
    Wiad Lek; 2003; 56(5-6):278-82. PubMed ID: 14526488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
    Pepin J
    Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.
    Khanna S; Pardi DS
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):409-16. PubMed ID: 20678014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Clostridium difficile-associated diarrhea.
    Malnick SD; Zimhony O
    Ann Pharmacother; 2002 Nov; 36(11):1767-75. PubMed ID: 12398575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium difficile infection after cardiac surgery: prevalence, morbidity, mortality, and resource utilization.
    Keshavamurthy S; Koch CG; Fraser TG; Gordon SM; Houghtaling PL; Soltesz EG; Blackstone EH; Pettersson GB
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):3157-65.e1-5. PubMed ID: 25242055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile infection.
    Kelly CP; LaMont JT
    Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.